↓ Skip to main content

Cochrane Database of Systematic Reviews

Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage

Overview of attention for article published in Cochrane database of systematic reviews, August 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

blogs
2 blogs
twitter
6 tweeters

Citations

dimensions_citation
125 Dimensions

Readers on

mendeley
179 Mendeley
Title
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage
Published in
Cochrane database of systematic reviews, August 2013
DOI 10.1002/14651858.cd001245.pub2
Pubmed ID
Authors

Merih I Baharoglu, Menno R Germans, Gabriel JE Rinkel, Ale Algra, Marinus Vermeulen, Jan van Gijn, Yvo BWEM Roos

Abstract

Rebleeding is an important cause of death and disability in people with aneurysmal subarachnoid haemorrhage. Rebleeding is probably related to dissolution of the blood clot at the site of aneurysm rupture by natural fibrinolytic activity. This review is an update of a previously published Cochrane review.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 179 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
China 1 <1%
Germany 1 <1%
Unknown 177 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 24 13%
Researcher 21 12%
Student > Doctoral Student 20 11%
Student > Bachelor 15 8%
Other 14 8%
Other 38 21%
Unknown 47 26%
Readers by discipline Count As %
Medicine and Dentistry 90 50%
Nursing and Health Professions 15 8%
Neuroscience 7 4%
Pharmacology, Toxicology and Pharmaceutical Science 3 2%
Psychology 2 1%
Other 9 5%
Unknown 53 30%

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 December 2021.
All research outputs
#1,896,650
of 22,026,693 outputs
Outputs from Cochrane database of systematic reviews
#4,257
of 12,167 outputs
Outputs of similar age
#16,694
of 179,060 outputs
Outputs of similar age from Cochrane database of systematic reviews
#38
of 115 outputs
Altmetric has tracked 22,026,693 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,167 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.8. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 179,060 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 115 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.